Clik here to view.
Gore RELINE MAX临床研究入组首例患者
亚利桑那州弗拉格斯塔夫 (美国商业资讯) — W. L. Gore & Associates (Gore) 宣布，Gore RELINE MAX临床研究现在入组首例患者，该上市后研究继续评估拥有肝素生物活性涂层的GORE® VIABAHN®内假体用于治疗股浅动脉(SFA)支架内再狭窄。原先的Gore RELINE临床研究结果支持了FDA于2014年对于GORE...
View ArticleClik here to view.
Blue Belt Technologies Announces the First Robotics-Assisted Partial Knee...
MINNEAPOLIS Blue Belt Technologies, a medical technology company specializing in robotic solutions for orthopedic surgery, announced the first Navio-assisted surgery performed in Australia utilizing...
View ArticleClik here to view.
V-Line Lifting, vs. Gravity and Time
SEOUL, South Korea In the recent years, Lifting by threads or laser and simple procedures such as fillers or Botox are becoming more popular to maintain youth and look younger. Types of threads used...
View ArticleClik here to view.
Cheekbone Reduction Surgery to Make Slim Face Shape from the Front and Side
SEOUL, South Korea A slim face shape is an element to look young and a condition for beauty. Even when having the same face size, if the cheekbone or square jaw are developed excessively, one’s face...
View ArticleClik here to view.
米国外科学会紀要に掲載：長期の良好な結果は複雑な腹壁ヘルニアの修復におけるGORE BIO-A組織補強材の有効性を実証
米アリゾナ州フラッグスタッフ （ビジネスワイヤ） — W. L. Gore & Associates, Inc.（ゴア）は本日、GORE® BIO-A®組織補強材の使用を評価する長期の前向き多施設試験1の最終結果を発表しました。GORE®...
View ArticleClik here to view.
Orthocell’s ‘Cell Factory’ Granted Patent in US
PERTH, Australia Regenerative medicine company Orthocell Limited is pleased to announce issuance of a US patent relating to its cell factory technology which produces native cartilage and bone...
View ArticleClik here to view.
新发表于《外科年报》的长期有利结果显示GORE BIO-A组织加固材料可有效修复复杂型腹部疝
亚利桑那州弗拉格斯塔夫 (美国商业资讯)–W. L. Gore & Associates, Inc. (Gore)今天发布了一项长期、前瞻性、多中心研究的最终结果，该研究评估生物合成网片GORE® BIO-A® 组织加固材料用于修复伤口污染患者的复杂型腹部疝(CVH)。该研究的主导研究者是克利夫兰诊所的Michael Rosen, MD，研究结果已被接受用于在《外科年报》发表。...
View ArticleClik here to view.
胸腹主动脉瘤临床研究完成首例植入
亚利桑那州弗拉格斯塔夫 (美国商业资讯) — W. L. Gore & Associates, Inc. (Gore)今天宣布，一项治疗累及腹支血管的主动脉瘤的临床研究完成了美国首例GORE® EXCLUDER®胸腹支内假体的植入。该手术的施术者是明尼苏达州罗切斯特梅奥诊所血管及血管内外科的外科教授Gustavo Oderich,...
View ArticleClik here to view.
胸腹部大動脈瘤の臨床試験で初の植え込みを完了
米アリゾナ州フラッグスタッフ （ビジネスワイヤ） — W. L. Gore & Associates, Inc.（ゴア）は本日、内臓分枝にまたがる大動脈瘤の治療を目的とした臨床試験で、米国初となるGORE® EXCLUDER® Thoracoabdominal Branch...
View ArticleClik here to view.
Telephus Medical LLC Announces Issuance of Japanese Patent for Anti-MRSA...
SAN DIEGO Telephus Medical LLC (Telephus), a biotechnology company focused on development of antibody therapies for antibiotic-resistant staphylococcal infections, today announced that the Japan...
View ArticleAcelity L.P. Inc. Reports Fourth Quarter and Full Year Financial Results for...
SAN ANTONIO Acelity L.P. Inc.: Fourth Quarter Financial Highlights Revenue for the fourth quarter of 2015 of $483.8 million, grew 0.2% as reported on a GAAP basis from the prior-year period and grew...
View ArticleClik here to view.
Turning Back the Clock Has Never Been So Simple! TL Thread Lifting
SEOUL, South Korea As education level & social status of women get elevated, the entry of women in public affairs has also expanded, making one’s beautiful appearance as one of the biggest...
View ArticleClik here to view.
Get Your V-line on with Personalized Genioplasty
SEOUL, South Korea Soft face shape despite your age determines you to be seen as a likable person or not. Recent craze of having a smooth face-line encouraged people to have non-surgical v-line...
View ArticleClik here to view.
No Revision EVER! The Safest & Most Successful Rhinoplasty
SEOUL, South Korea Safe to say, shape of your nose probably has the largest influence on deciding your overall image because it is located in the center of your face. In the recent years, eyeplasty...
View ArticleClik here to view.
Hoya Reports Third Quarter Results; Record Nine Months Results
TOKYO Hoya Corporation (TOKYO: 7741) today announced financial results for the third quarter ended December 31, 2015. During the quarter, the Group sales totaled 127,645 million yen, decreasing by...
View ArticleClik here to view.
Cytori Cell Therapy Safe and Potentially Effective in EU Phase I Erectile...
SAN DIEGO Cytori Therapeutics, Inc. (NASDAQ: CYTX) announced today the publication of the results of an investigator initiated Phase I clinical trial using Cytori Cell Therapy™ for the treatment of...
View ArticleClik here to view.
Glaukos Establishes Direct Sales Organization and Launches iStent inject®...
LAGUNA HILLS, Calif. Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to...
View ArticleClik here to view.
新しい臨床試験でマシモの予備酸素摂量指数は小児患者における切迫した酸素飽和度低下の発見で臨床医に貢献
スイス・ヌーシャテル （ビジネスワイヤ） — マシモ（NASDAQ: MASI）は本日、新しい臨床試験でマシモの予備酸素摂量指数（Oxygen Reserve...
View ArticleClik here to view.
Japanese Patent Office Issues Decision to Grant Patent for USMI’s Canady...
TAKOMA PARK, Md. US Medical Innovations, LLC (USMI), a U.S.-based biomedical device specification manufacturing company and subsidiary of US Patent Innovations, LLC (USPI), announces the Japanese...
View ArticleClik here to view.
新临床研究显示，Masimo的氧储备指数可帮助临床医生识别儿科患者的急性去氧饱和
瑞士纳沙泰尔 (美国商业资讯) — Masimo (NASDAQ: MASI)今天宣布，一项新的临床研究显示，Masimo的氧储备指数(ORI™)可帮助临床医生早期识别儿科患者在麻醉诱导期间的急性去氧饱和，该指数是首个可洞悉患者在补充氧气时氧储备的无创连续参数。1 Smart News Releases（智能新闻稿）是一个多媒体平台。在此处查看完整新闻稿：...
View Article